On assessing survival benefit of immunotherapy using long-term restricted mean survival time
From MaRDI portal
Publication:6617469
DOI10.1002/SIM.9662zbMATH Open1545.62353MaRDI QIDQ6617469FDOQ6617469
Lu Tian, Miki Horiguchi, Hajime Uno
Publication date: 11 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Cites Work
- Title not available (Why is that?)
- Title not available (Why is that?)
- Checking the Cox model with cumulative sums of martingale-based residuals
- Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations
- Sequential Methods for Comparing Years of Life Saved in the Two‐Sample Censored Data Problem
- On the restricted mean survival time curve in survival analysis
- On the empirical choice of the time window for restricted mean survival time
- On permutation tests for comparing restricted mean survival time with small sample from randomized trials
- Window mean survival time
This page was built for publication: On assessing survival benefit of immunotherapy using long-term restricted mean survival time
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6617469)
